Investing Profile

Stephen Curtis

InvestorVC
Managing Director - Oncology Innovations at MPM BioImpact
Photo of Stephen Curtis, Managing Partner at MPM BioImpact

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4899 CONNECTIONS
Cornell University Network
255 CONNECTIONS
Kauffman Fellows Network
152 CONNECTIONS
Kauffman Fellows Network
152 CONNECTIONS
Kauffman Fellows Network
152 CONNECTIONS
MPM BioImpact Managing Partner
$100K - $5.0M
$1.5M
Honors Research Student HotmailPresent
Research Intern BASFPresent
Research Assistant AllerganPresent
Doctoral Student Harvard Medical SchoolPresent
Market Analyst Intern Siemens HealthineersPresent
Licensing & Intellectual Property | Biopharmaceutical Leadership Development Program Reata Pharmaceuticals, Inc.Present
Bioscience Ventures 2M Companies Inc.Present
Fellow - Class 20 Kauffman FellowsPresent
Co-Chair - Healthcare SIG Kauffman FellowsPresent
Co-Chair - Boston Chapter Kauffman FellowsPresent
Sr Director, Business Development - Emerging Technology and Innovation Eli Lilly and CompanyPresent
Principal MPM BioImpactPresent
Managing Director - Oncology Innovations MPM BioImpactPresent
Board Observer Dyne TherapeuticsPresent
Stealth NewCos - Founding Board Member and COO/CBO MPM BioImpactPresent
Interim COO / Board of Directors NextPoint Therapeutics, Inc.Present
Interim VP, Innovation & Impact Investing and Managing Director BrightEdge - American Cancer SocietyPresent
Strategy / Business Development Consultant NextPoint Therapeutics, Inc.Present
Cornell University Bachelor of Science (B.S.) Molecular and Cellular Biology; Applied Economics and Management
Harvard Medical School Doctor of Philosophy (Ph.D.) Biological and Biomedical Sciences